Here's the hot stuff from Leidos Holdings
$LDOS (+0,1%) (NYSE: LDOS) Q2 2026 Earnings Release, just released on August 4, 2026, before U.S. markets opened:
🚀 Top-Line Performance & Order Boost
U.S. defense and technology giant Leidos significantly beat Wall Street expectations in the second quarter of 2026 (ending July 3, 2026) and reported strong revenue growth:
Total revenue: Climbed by +7% YoY to $4.56 billion (compared to $4.25 billion in the prior year) and significantly exceeded the Wall Street consensus of $4.44 billion.
New Order Volume (Contract Awards): Secured a whopping $5.0 billion for the quarter.
Growth drivers: Strong momentum, particularly in the three core pillars Defense Tech, Energy Infrastructure and Cyber.
🔮 Profitability & Massive Cash Generation
Although high margin figures from the prior year slightly weighed on operating profit, Leidos significantly exceeded analysts’ estimates for earnings per share:
Non-GAAP Diluted EPS: Reached $3.26 (+2% YoY after $3.21 the previous year) and beats the consensus forecast of ~$2.89–$2.90 by a wide margin!
Adjusted EBITDA: Reached $631 million with a strong adjusted EBITDA margin of 13.8%.
Free Cash Flow (Non-GAAP): Reached an impressive $761 million in free cash flow (operating cash flow at $793 million).
🤖 2026 Full-Year Forecast Raised (Guidance Upgrade)
Due to the strong operating performance in the first half of the year, CEO Tom Bell is raising the bar for the full year 2026 across all key metrics:
Upgrades across the board: Leidos is raising its full-year forecasts for revenue, earnings, and free cash flow .
Greater visibility: Management points to increased transparency and stability in the long-term Managed Healthcare.
⚡ 💡 Jack’s Take
A textbook beat & raise from the defense tech sector! Anyone who was worried about potential headwinds or margin pressure will be proven wrong by $4.56 billion in revenue (+7%), an EPS beat of $3.26 vs. the $2.89 consensus, and a massive $761 million in free cash flow. With $5 billion in new orders secured and an upwardly revised full-year forecast, Leidos is proving its exceptional operational position as a high-quality defensive compounder!